3/5
09:28 am
evax
Evaxion announces business update and full year 2025 financial results
Medium
Report
Evaxion announces business update and full year 2025 financial results
3/5
08:02 am
evax
Evaxion plans to file 2025 annual report later today
Medium
Report
Evaxion plans to file 2025 annual report later today
3/2
08:00 am
evax
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
Low
Report
Evaxion to announce business update and full year 2025 financial results on March 5, 2026
2/19
09:00 am
evax
Evaxion A/S (NASDAQ:EVAX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Evaxion A/S (NASDAQ:EVAX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
1/13
08:00 am
evax
Evaxion expands AI-Immunology™ platform into autoimmune diseases
Low
Report
Evaxion expands AI-Immunology™ platform into autoimmune diseases
1/13
04:05 am
evax
Evaxion A/S (NASDAQ:EVAX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Evaxion A/S (NASDAQ:EVAX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/7
08:00 am
evax
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
Medium
Report
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
12/19
07:49 am
evax
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2 [Yahoo! Finance]
High
Report
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2 [Yahoo! Finance]
12/19
07:00 am
evax
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
High
Report
Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2
12/6
02:00 pm
evax
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
High
Report
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting